RCGP SCA Algorithm โ UK Primary Care
Ask about suicidal thoughts directly at the first contact โ asking does not increase risk. A positive answer needs a clinical conversation, not a score.
NICE NG225 (2022) advises against using risk assessment tools and scales to predict future suicide or repetition of self-harm, against using them to decide who should or should not be offered treatment, and against global low/medium/high risk stratification. Instead, have a person-centred conversation about the person's thoughts, intent, plan, means, previous self-harm, alcohol and drugs, circumstances and protective factors, and agree a safety plan. PHQ-9 item 9 is a prompt, not a risk assessment.
Most people who die by suicide after self-harm had been judged "low risk" on standard tools โ which is why the conversation, not the score, decides the plan.
Screening for past mania before prescribing matters: an antidepressant alone can tip someone with bipolar disorder into mania or a mixed state. Asking who lives at home is both a protective-factor question and a safeguarding question โ depression in a parent or carer can affect children and dependants.
Drug-induced mood change is easy to miss because the temporal link is weeks to months. Do not stop an important medicine without weighing risk and benefit.
Hypothyroidism, anaemia, B12 deficiency, hypercalcaemia and diabetes can all present as low mood and fatigue. Test when the history points to them, rather than ordering a fixed panel for everyone. A new depression in later life with cognitive change warrants looking for dementia, vascular disease and medication effects.
Grief and adjustment are normal responses that usually need support rather than medicines; depression can develop on top of either, so reassess if symptoms persist or deepen. Bipolar depression is commonly first diagnosed as unipolar depression โ the mania screen is the safeguard.
NICE NG222 asks for a shared decision on treatment: the least intrusive effective option first for less severe depression, and a combination of psychological therapy and an antidepressant as the most effective option for more severe depression.
Most low mood is managed in primary care with NHS Talking Therapies. Specialist mental-health input is for risk, psychosis, bipolar disorder, severe or treatment-resistant depression and complex comorbidity.
Next steps: see Depression ยท Anxiety disorders ยท Postnatal depression ยท Harmful drinking and alcohol dependence ยท Hypothyroidism ยท Dementia
NICE NG222 (2022) ranks guided self-help first for less severe depression and advises against routinely offering antidepressants first-line unless the person prefers them; SSRIs are the preferred antidepressant because of safety and tolerability. For more severe depression, combined individual CBT and an antidepressant is the most clinically and cost-effective option. Second-line choices, switching and long-term continuation are in the Depression protocol.
Behavioural activation and exercise both have evidence in depression and give the person something active to do while waiting for therapy. Practical stressors such as debt are strongly linked with depression and suicide risk.
The early weeks after starting an antidepressant, and after a crisis or discharge, are periods of higher risk. A named follow-up date, a written safety plan and crisis numbers in the person's phone are simple, high-value safety measures.